ロングリードシーケンスの世界市場

ロングリードシーケンスの世界市場は2030年までに38億米ドルに達する見込み

2024年に7億5,680万米ドルと推定されるロングリードシーケンスの世界市場は、分析期間2024-2030年にCAGR 30.8%で成長し、2030年には38億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである機器は、CAGR 32.5%を記録し、分析期間終了時には26億米ドルに達すると予測されます。消耗品セグメントの成長率は、分析期間中CAGR 28.3％と推定されます。

米国市場は推定2億620万米ドル、中国はCAGR40.4％で成長予測

米国のロングリードシーケンス市場は、2024年に2億620万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを40.4%として、2030年までに9億7,320万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ24.7%と27.9%と予測されています。欧州では、ドイツがCAGR 26.1%で成長すると予測されています。

世界のロングリードシーケンス市場- 主要動向と促進要因まとめ

ロングリードシーケンスとは何か、なぜゲノミクスに革命をもたらすのか？

ロングリードシーケンスは、第3世代シーケンサーとも呼ばれ、1回のパスで数万塩基対を超える長さの塩基配列を読み取ることができる先進的なDNAシーケンス技術を指します。DNA断片を小さなビット（通常100-300塩基対）で読み取るショートリードシーケンスとは異なり、ロングリードシーケンスはショートリード技術では効果的に解決できない反復領域や複雑な領域にまたがることで、ゲノムのより完全で正確な画像を提供します。このため、de novoゲノムアセンブリ、構造バリアントの検出、エピジェネティック解析、未解析のゲノム領域の研究に特に有用です。

Pacific Biosciences（PacBio）やOxford Nanopore Technologies（ONT）のようなプロバイダーが提供するテクノロジーは、この分野の最前線にあり、ロングリード解析のための高度にスケーラブルで、ますますコスト効率の高いソリューションを提供しています。これらのプラットフォームは、ヒト疾患、微生物群集、植物ゲノム、がんゲノムに関する包括的な洞察を可能にすることで、ゲノム研究や臨床診断に変革をもたらしつつあります。全長転写産物やメチル化パターンを捕捉する能力も、機能ゲノミクスやトランスクリプトーム・プロファイリングを強化します。より正確で完全な遺伝子データへの需要が高まるにつれ、ロングリードシーケンスは現代の分子生物学においてますます中心的な役割を果たしています。

どのようなイノベーションと使用事例がロングリードシーケンスの採用を加速していますか？

ロングリードシーケンスの進化は、リード精度、スループット、ポータビリティの継続的な進歩によって形作られています。PacBio社のHiFiリードとOxford Nanopore社のQ20+ケミストリーの最近の改良により、ロングリードのベースコール精度が大幅に改善され、精度と信頼性の両面でショートリードプラットフォームと競合できるようになりました。これらの技術革新により、ロングリードシーケンスは、構造的バリアント、遺伝子融合、大規模な挿入や欠失の正確な検出が重要である臨床診断、個別化医療、希少疾患の同定に幅広く応用できるようになりました。

ロングリード技術は、マイクロバイオーム解析やメタゲノム解析においてもますます利用されるようになっており、複雑なサンプルから微生物ゲノムを完全に解析する能力によって、微生物の多様性、抗生物質耐性、病原体の監視に関する理解が深まっています。腫瘍学では、ロングリードが腫瘍の不均一性や体細胞構造の変異の検出に役立っており、治療方針の決定に役立っています。ONT社のMinIONデバイスのようなプラットフォームの可搬性は、感染症追跡、環境ゲノミクス、食品安全性検査などの現場やポイントオブケアでのシーケンシングを可能にしています。さらに、ロングリードシーケンスは、特に集団規模のゲノムプロジェクトにおいて、コスト、精度、カバレッジの深さのバランスをとるために、ロングリードとショートリードを組み合わせたハイブリッドシーケンス戦略に組み込まれています。

ロングリードシーケンス市場拡大の要因は？

世界のロングリードシーケンス市場の成長は、包括的なゲノムの知見に対する需要の増加、シーケンスコストの低下、臨床および農業ゲノミクスにおけるアプリケーションの拡大など、いくつかの要因によってもたらされています。研究者や臨床医が複雑な遺伝子領域や構造的変異の解読を求める中、ショートリードシーケンスでは見逃されがちな、より正確で完全なゲノムプロファイリングのためにロングリードプラットフォームの採用が増加しています。この需要は、ゲノムの複雑性から高解像度の解析が必要とされる腫瘍学、希少疾患診断、神経遺伝学、出生前スクリーニングにおいて特に顕著です。

さらに、個別化医療や精密医療の普及が進み、個々のゲノムデータから実用的な知見を得ることができる技術の必要性が高まっています。集団シーケンシング・プロジェクトや希少疾患登録など、政府が支援するゲノム関連イニシアチブも、データの完全性と有用性を確保するためにロングリード・プラットフォームを取り入れることで、市場の成長に寄与しています。さらに、農業バイオテクノロジーや植物ゲノミクスへの投資の増加により、作物形質解析、ゲノム編集の検証、生物多様性研究におけるロングリードの利用が拡大しています。シーケンス化学、デバイスの小型化、クラウドベースのバイオインフォマティクスにおける継続的な技術革新は、新規ユーザーの参入障壁を下げ、学術、臨床、商業の各領域における市場導入をさらに加速しています。

セグメント

製品（装置、消耗品、サービス）、技術（1分子リアルタイムシーケンス、ナノポアシーケンス、その他）、ワークフロー（プレシーケンス、シーケンス、データ解析）、最終用途（全ゲノムシーケンス、ターゲットシーケンス、メタゲノミクス、RNAシーケンス、エピジェネティクス、その他）、最終用途（学術・研究機関、病院・クリニック、製薬・バイオテクノロジー企業、その他）

調査対象企業の例

• 10x Genomics
• Agilent Technologies
• BGI Genomics
• Bionano Genomics
• CD Genomics
• Element Biosciences
• FG Technologies
• GENEWIZ（Azenta Life Sciences）
• Illumina, Inc.
• MGI Tech Co., Ltd.
• MicrobesNG
• Oxford Nanopore Technologies
• Pacific Biosciences（PacBio）
• Qiagen
• Quantapore, Inc.
• Singular Genomics
• Stratos Genomics
• Thermo Fisher Scientific
• Ultima Genomics
• Universal Sequencing Technology Corp.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Long Read Sequencing Market to Reach US$3.8 Billion by 2030

The global market for Long Read Sequencing estimated at US$756.8 Million in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 30.8% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 32.5% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Consumables segment is estimated at 28.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$206.2 Million While China is Forecast to Grow at 40.4% CAGR

The Long Read Sequencing market in the U.S. is estimated at US$206.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$973.2 Million by the year 2030 trailing a CAGR of 40.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 24.7% and 27.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 26.1% CAGR.

Global Long Read Sequencing Market - Key Trends & Drivers Summarized

What Is Long Read Sequencing and Why Is It Revolutionizing Genomics?

Long read sequencing, also known as third-generation sequencing, refers to advanced DNA sequencing technologies capable of reading extended nucleotide sequences in a single pass-often exceeding tens of thousands of base pairs. Unlike short-read sequencing, which reads DNA fragments in small bits (typically 100-300 base pairs), long read sequencing provides a more complete and accurate picture of the genome by spanning repetitive and complex regions that short-read technologies cannot resolve effectively. This makes it especially valuable for de novo genome assembly, structural variant detection, epigenetic analysis, and studying previously uncharacterized genomic regions.

Technologies from providers like Pacific Biosciences (PacBio) and Oxford Nanopore Technologies (ONT) are at the forefront of this field, offering highly scalable and increasingly cost-effective solutions for long read analysis. These platforms are transforming genomics research and clinical diagnostics by enabling comprehensive insights into human diseases, microbial communities, plant genomics, and cancer genomics. Their ability to capture full-length transcripts and methylation patterns also enhances functional genomics and transcriptome profiling. As the demand for more precise and complete genetic data grows, long read sequencing is playing an increasingly central role in modern molecular biology.

What Innovations and Use Cases Are Accelerating the Adoption of Long Read Sequencing?

The evolution of long read sequencing is being shaped by continuous advancements in read accuracy, throughput, and portability. Recent iterations of PacBio's HiFi reads and Oxford Nanopore’s Q20+ chemistry have significantly improved the base-calling accuracy of long reads, making them competitive with short-read platforms in both precision and reliability. These innovations have expanded long read sequencing’s applicability across clinical diagnostics, personalized medicine, and rare disease identification, where accurate detection of structural variants, gene fusions, and large insertions or deletions is critical.

Long read technologies are also being increasingly used in microbiome analysis and metagenomics, where the ability to fully resolve microbial genomes from complex samples enhances the understanding of microbial diversity, antibiotic resistance, and pathogen surveillance. In oncology, long reads are aiding in the detection of tumor heterogeneity and somatic structural variations that inform treatment decisions. The portability of platforms like ONT’s MinION device is enabling in-field and point-of-care sequencing for infectious disease tracking, environmental genomics, and food safety testing. Furthermore, long read sequencing is being integrated into hybrid sequencing strategies-combining long and short reads-to balance cost, accuracy, and depth of coverage, particularly in population-scale genome projects.

What Factors Are Fueling the Expansion of the Long Read Sequencing Market?

The growth in the global long read sequencing market is driven by several factors, including increasing demand for comprehensive genomic insights, declining sequencing costs, and expanding applications in clinical and agricultural genomics. As researchers and clinicians seek to decode complex genetic regions and structural variations that short-read sequencing often misses, long read platforms are being increasingly adopted for more accurate and complete genomic profiling. This demand is particularly pronounced in oncology, rare disease diagnostics, neurogenetics, and prenatal screening, where genomic complexity requires high-resolution analysis.

In addition, the rising prevalence of personalized and precision medicine is catalyzing the need for technologies that can deliver actionable insights from individual genomic data. Government-backed genomic initiatives, such as national population sequencing projects and rare disease registries, are also contributing to market growth by incorporating long read platforms to ensure data completeness and utility. Moreover, growing investments in agricultural biotechnology and plant genomics are expanding the use of long reads in crop trait analysis, genome editing validation, and biodiversity studies. The continuous innovation in sequencing chemistry, device miniaturization, and cloud-based bioinformatics is lowering the entry barrier for new users, further accelerating market adoption across academic, clinical, and commercial domains.

SCOPE OF STUDY:

The report analyzes the Long Read Sequencing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Instruments, Consumables, Services); Technology (Single Molecule Real Time Sequencing, Nanopore Sequencing, Others); Workflow (Pre-sequencing, Sequencing, Data Analysis); Application (Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics, Others); End-Use (Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• 10x Genomics
• Agilent Technologies
• BGI Genomics
• Bionano Genomics
• CD Genomics
• Element Biosciences
• FG Technologies
• GENEWIZ (Azenta Life Sciences)
• Illumina, Inc.
• MGI Tech Co., Ltd.
• MicrobesNG
• Oxford Nanopore Technologies
• Pacific Biosciences (PacBio)
• Qiagen
• Quantapore, Inc.
• Singular Genomics
• Stratos Genomics
• Thermo Fisher Scientific
• Ultima Genomics
• Universal Sequencing Technology Corp.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Long Read Sequencing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rapid Advancements in Third-Generation Sequencing Technologies Propel Market Expansion
  • Growing Demand for Accurate Structural Variant Detection Drives Adoption of Long Read Platforms
  • Rising Genomic Research Funding Worldwide Accelerates Technology Penetration
  • Need for Complete and Unbiased Genome Assembly Expands Use in Complex Genomic Regions
  • Integration with CRISPR-Based Applications Enhances Relevance in Functional Genomics
  • Increased Use in Oncology and Rare Disease Diagnostics Strengthens Clinical Utility
  • Bioinformatics Advancements Improve Accuracy and Cost-Efficiency of Data Interpretation
  • Collaborations Between Academic Labs and Sequencing Companies Accelerate Innovation Cycles
  • Expanding Role in Microbiome and Metagenomics Research Drives Application Breadth
  • Global Precision Medicine Initiatives Fuel Demand for Long Read Sequencing Tools
  • Use in Epigenetics and Methylation Analysis Expands Research Applications
  • Hybrid Sequencing Approaches (Short + Long Reads) Gain Momentum for Comprehensive Analysis
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Long Read Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Long Read Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Long Read Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Long Read Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Targeted Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Targeted Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Targeted Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Metagenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Metagenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Metagenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for RNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for RNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for RNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Single Molecule Real Time Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Single Molecule Real Time Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Single Molecule Real Time Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Pre-sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Pre-sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Pre-sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for Data Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 62: USA Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: USA 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 74: USA Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: USA Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: USA 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Canada 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Canada 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 89: Canada Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Canada Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Canada 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• JAPAN
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Japan 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Japan 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 98: Japan Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Japan Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Japan 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 101: Japan Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Japan Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Japan 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 104: Japan Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Japan Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Japan 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• CHINA
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 107: China Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: China 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 110: China Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: China Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: China 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 113: China Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: China Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: China 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 116: China Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: China Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: China 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 119: China Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: China Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: China 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• EUROPE
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Long Read Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Europe 15-Year Perspective for Long Read Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 125: Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Europe Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Europe 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 128: Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Europe Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Europe 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 131: Europe Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Europe Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Europe 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 134: Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Europe Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Europe 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 137: Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Europe Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Europe 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• FRANCE
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 140: France Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: France Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: France 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 143: France Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: France Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: France 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 146: France Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: France Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: France 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 149: France Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: France Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: France 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 152: France Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: France Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: France 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• GERMANY
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 155: Germany Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Germany Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Germany 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 158: Germany Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Germany Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Germany 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 161: Germany Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Germany Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Germany 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 164: Germany Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Germany Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Germany 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 167: Germany Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Germany Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Germany 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 170: Italy Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Italy Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Italy 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 173: Italy Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Italy Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Italy 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 176: Italy Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Italy Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Italy 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 179: Italy Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Italy Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Italy 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 182: Italy Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Italy Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Italy 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 185: UK Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: UK Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: UK 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 188: UK Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: UK Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: UK 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 191: UK Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: UK Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: UK 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 194: UK Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UK Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: UK 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 197: UK Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: UK Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: UK 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 200: Spain Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Spain Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Spain 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 203: Spain Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Spain Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Spain 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 206: Spain Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Spain Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Spain 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 209: Spain Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Spain Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Spain 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 212: Spain Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Spain Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Spain 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 215: Russia Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Russia Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Russia 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 218: Russia Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Russia Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Russia 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 221: Russia Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Russia Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Russia 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 224: Russia Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Russia Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Russia 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 227: Russia Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Russia Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Russia 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Europe Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Europe 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Europe Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Europe 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Europe Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Europe Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Europe 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Europe Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Europe 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Europe Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Europe 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 246: Asia-Pacific Historic Review for Long Read Sequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Asia-Pacific 15-Year Perspective for Long Read Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 248: Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Asia-Pacific Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Asia-Pacific 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 251: Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Asia-Pacific Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Asia-Pacific 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Asia-Pacific Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Asia-Pacific 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 257: Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Asia-Pacific Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Asia-Pacific 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 260: Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Asia-Pacific Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Asia-Pacific 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 263: Australia Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Australia Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Australia 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 266: Australia Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Australia Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Australia 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 269: Australia Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Australia Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Australia 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 272: Australia Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Australia Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Australia 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 275: Australia Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Australia Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Australia 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• INDIA
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 278: India Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: India Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: India 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 281: India Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: India Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: India 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 284: India Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: India Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: India 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 287: India Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: India Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: India 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 290: India Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: India Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: India 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 293: South Korea Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: South Korea Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: South Korea 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 296: South Korea Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: South Korea Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: South Korea 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 299: South Korea Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: South Korea Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: South Korea 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 302: South Korea Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: South Korea Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: South Korea 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 305: South Korea Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: South Korea Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: South Korea 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 308: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Asia-Pacific Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Asia-Pacific 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Asia-Pacific Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Asia-Pacific 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Asia-Pacific Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Asia-Pacific 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Asia-Pacific Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Asia-Pacific 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 320: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Asia-Pacific Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Rest of Asia-Pacific 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 323: Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 324: Latin America Historic Review for Long Read Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Latin America 15-Year Perspective for Long Read Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 326: Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Latin America Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Latin America 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 329: Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Latin America Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Latin America 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 332: Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Latin America Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Latin America 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 335: Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Latin America Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Latin America 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 338: Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Latin America Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Latin America 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 341: Argentina Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Argentina Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Argentina 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 344: Argentina Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Argentina Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Argentina 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 347: Argentina Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Argentina Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Argentina 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 350: Argentina Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Argentina Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Argentina 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 353: Argentina Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Argentina Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Argentina 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 356: Brazil Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Brazil Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Brazil 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 359: Brazil Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Brazil Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Brazil 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 362: Brazil Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Brazil Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: Brazil 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 365: Brazil Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Brazil Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: Brazil 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 368: Brazil Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Brazil Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: Brazil 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 371: Mexico Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Mexico Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: Mexico 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 374: Mexico Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Mexico Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: Mexico 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 377: Mexico Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Mexico Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: Mexico 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 380: Mexico Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Mexico Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Mexico 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 383: Mexico Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Mexico Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Mexico 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 386: Rest of Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Latin America Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Latin America 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Latin America Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Latin America 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Latin America Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Latin America 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 395: Rest of Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Latin America Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: Rest of Latin America 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 398: Rest of Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Latin America Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 400: Rest of Latin America 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 401: Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 402: Middle East Historic Review for Long Read Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 403: Middle East 15-Year Perspective for Long Read Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 404: Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Middle East Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 406: Middle East 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 407: Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Middle East Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 409: Middle East 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 410: Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Middle East Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 412: Middle East 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 413: Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Middle East Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 415: Middle East 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 416: Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Middle East Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 418: Middle East 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 419: Iran Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Iran Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 421: Iran 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 422: Iran Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Iran Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 424: Iran 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 425: Iran Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Iran Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 427: Iran 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 428: Iran Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 429: Iran Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 430: Iran 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 431: Iran Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 432: Iran Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 433: Iran 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 434: Israel Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 435: Israel Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 436: Israel 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 437: Israel Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 438: Israel Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 439: Israel 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 440: Israel Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 441: Israel Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 442: Israel 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 443: Israel Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 444: Israel Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 445: Israel 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 446: Israel Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 447: Israel Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 448: Israel 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 449: Saudi Arabia Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 450: Saudi Arabia Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 451: Saudi Arabia 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 452: Saudi Arabia Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 453: Saudi Arabia Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 454: Saudi Arabia 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 455: Saudi Arabia Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 456: Saudi Arabia Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 457: Saudi Arabia 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 458: Saudi Arabia Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 459: Saudi Arabia Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 460: Saudi Arabia 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 461: Saudi Arabia Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 462: Saudi Arabia Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 463: Saudi Arabia 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 464: UAE Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 465: UAE Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 466: UAE 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 467: UAE Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 468: UAE Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 469: UAE 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 470: UAE Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 471: UAE Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 472: UAE 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 473: UAE Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 474: UAE Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 475: UAE 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 476: UAE Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 477: UAE Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 478: UAE 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 479: Rest of Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 480: Rest of Middle East Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 481: Rest of Middle East 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 482: Rest of Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 483: Rest of Middle East Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 484: Rest of Middle East 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 485: Rest of Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 486: Rest of Middle East Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 487: Rest of Middle East 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 488: Rest of Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 489: Rest of Middle East Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 490: Rest of Middle East 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 491: Rest of Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 492: Rest of Middle East Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 493: Rest of Middle East 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
• AFRICA
  • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 494: Africa Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 495: Africa Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 496: Africa 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
  • TABLE 497: Africa Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 498: Africa Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 499: Africa 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 500: Africa Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 501: Africa Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 502: Africa 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 503: Africa Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 504: Africa Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 505: Africa 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 506: Africa Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 507: Africa Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 508: Africa 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030

IV. COMPETITION